Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Acumen Pharmaceuticals Inc (ABOS)

Acumen Pharmaceuticals Inc (ABOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Acumen Pharmaceuticals to Participate in the 7th Annual Evercore ISI HealthCONx Conference GlobeNewswire - Tue Nov 26, 3:00PM CST

ABOS : 1.7700 (-4.32%)
Acumen Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business Highlights GlobeNewswire - Tue Nov 12, 6:00AM CST

ABOS : 1.7700 (-4.32%)
Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference GlobeNewswire - Mon Nov 11, 3:00PM CST

ABOS : 1.7700 (-4.32%)
Acumen Pharmaceuticals to Participate in the UBS Global Healthcare Conference GlobeNewswire - Wed Nov 6, 3:00PM CST

ABOS : 1.7700 (-4.32%)
Acumen Pharmaceuticals Appoints Dr. Amy Schacterle as Chief Regulatory Officer & Head of Quality GlobeNewswire - Wed Nov 6, 7:00AM CST

ABOS : 1.7700 (-4.32%)
Acumen Pharmaceuticals to Report Third Quarter Results on Nov. 12, 2024 GlobeNewswire - Tue Nov 5, 3:00PM CST

ABOS : 1.7700 (-4.32%)
Acumen Pharmaceuticals Presents Innovative Trial Screening Advancements Utilizing pTau217 Assay in Phase 2 Study of Sabirnetug for Early Alzheimer’s Disease at the 17th Annual Clinical Trials on Alzheimer’s Disease Conference GlobeNewswire - Thu Oct 31, 7:05AM CDT

ABOS : 1.7700 (-4.32%)
Acumen Pharmaceuticals to Deliver Late-Breaking Presentation at 17th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference GlobeNewswire - Wed Oct 23, 7:00AM CDT

ABOS : 1.7700 (-4.32%)
Buy, Sell - Buy enter button by Ardasavasciogullari via iStock
2 'Strong Buy'-Rated Stocks That Wall Street Believes Can Soar Over 360% Barchart - Mon Aug 19, 1:01PM CDT

Analysts see enormous long-term potential in these two penny stocks.

ABOS : 1.7700 (-4.32%)
ELDN : 4.19 (-3.90%)
$SPX : 5,974.07 (+0.73%)
Dollars and Wallets - Money Coming in Mail Stimulus
2 Penny Stocks Wall Street Expects to Soar Over 400% Barchart - Mon Jul 22, 12:12PM CDT

These two penny stock companies, while risky and volatile, have the potential to generate massive returns, according to Wall Street's price forecasts.

ABOS : 1.7700 (-4.32%)
$SPX : 5,974.07 (+0.73%)
ELDN : 4.19 (-3.90%)

Barchart Exclusives

Why This Dividend Stock Just Scored a Rare Upgrade Barchart - 6 minutes ago
Bristol Myers Squibb, a global biopharma company, has received a rare upgrade from Jefferies due to its promising pipeline and strategic partnerships. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot